Resultats de la cerca - Lisa D. Laury‐Kleintop

  • Mostrar 1 - 7 resultats de 7
Refinar resultats
  1. 1
    Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive ‘Cold’ Tumors ‘Hot’

    Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive ‘Cold’ Tumors ‘Hot’ per George C. Prendergast, Arpita Mondal, Souvik Dey, Lisa D. Laury‐Kleintop, Alexander J. Muller

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Novel Tryptophan Catabolic Enzyme IDO2 Is the Preferred Biochemical Target of the Antitumor Indoleamine 2,3-Dioxygenase Inhibitory Compound <scp>d</scp>-1-Methyl-Tryptophan

    Novel Tryptophan Catabolic Enzyme IDO2 Is the Preferred Biochemical Target of the Antitumor Indoleamine 2,3-Dioxygenase Inhibitory Compound <scp>d</scp>-1-Methyl-Tryptophan per Richard Metz, James B. DuHadaway, Uma Kamasani, Lisa D. Laury‐Kleintop, Alexander J. Muller, George C. Prendergast

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer

    Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer per George C. Prendergast, Courtney Smith, Sunil Thomas, Laura Mandik‐Nayak, Lisa D. Laury‐Kleintop, Richard Metz, Alexander J. Muller

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis

    Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis per Lauren M.F. Merlo, Samantha Grabler, James B. DuHadaway, Elizabeth Pigott, Kaylend Manley, George C. Prendergast, Lisa D. Laury‐Kleintop, Laura Mandik‐Nayak

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells

    The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells per Sara Trabanelli, Darina Očadlíková, Marilena Ciciarello, Valentina Salvestrini, Mariangela Lecciso, Camilla Jandus, Richard Metz, Cecilia Evangelisti, Lisa D. Laury‐Kleintop, Pedro Romero, George C. Prendergast, Antonio Curti, Roberto M. Lemoli

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Reduction of the expression of the late-onset Alzheimer’s disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model

    Reduction of the expression of the late-onset Alzheimer’s disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model per Robert J. Andrew, Pierre De Rossi, Phuong Nguyen, Haley R. Kowalski, Aleksandra J. Recupero, Thomas Guerbette, Sofia V. Krause, Richard C. Rice, Lisa D. Laury‐Kleintop, Steven L. Wagner, Gopal Thinakaran

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development

    IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development per Courtney Smith, Mee Young Chang, Katherine H. Parker, Daniel W. Beury, James B. DuHadaway, Hollie E. Flick, Janette Boulden, Erika Sutanto‐Ward, Alejandro Peralta Soler, Lisa D. Laury‐Kleintop, Laura Mandik‐Nayak, Richard Metz, Suzanne Ostrand‐Rosenberg, George C. Prendergast, Alexander J. Muller

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: